価格表
在庫・価格 : 2026年04月09日 08時04分 現在
| 商品名 | 商品コード | メーカー | 包装 | 価格 | 在庫 | リスト |
|---|---|---|---|---|---|---|
|
PDGF-DD, Human, Recombinant データシート |
1159-SB-025 |
RSDアールアンドディー システムズ R&D Systems, Inc. |
25 μg | ¥71,000 | 1個 | 追加 |
在庫・価格 : 2026年04月09日 08時04分 現在
使用文献
- No.: 1
-
文献情報:
Rovida E et al. ERK5 differentially regulates PDGF-induced proliferation and migration of hepatic stellate cells. J. Hepatol. 2008 Jan;48(1):107-15
Rovida E et al
2008/01/01
-
備考:
Species: Human, Application: Bioassay, Sample type: Whole Cells -
参照:
- No.: 2
-
文献情報:
McCabe KL et al. Essential role for PDGF signaling in ophthalmic trigeminal placode induction. Development 2008 May;135(10):1863-74
McCabe KL et al
2008/01/01
-
備考:
Species: Chicken, Application: In Vivo, In Vivo -
参照:
- No.: 3
-
文献情報:
W奪gs辰ter D et al. Effects of PDGF-C and PDGF-D on monocyte migration and MMP-2 and MMP-9 expression. Atherosclerosis 2009 Feb;202(2):415-23
W奪gs辰ter D et al
2009/01/01
-
備考:
Application: Bioassay, Sample Type: Cell Culture -
参照:
- No.: 4
-
文献情報:
Ammoun S et al. Dissecting and targeting the growth factor-dependent and growth factor-independent extracellular signal-regulated kinase pathway in human schwannoma. Cancer Res. 2008 Jul;68(13):5236-45
Ammoun S et al
2008/01/01
-
備考:
Species: Human, Application: Bioassay, Whole Cells -
参照:
- No.: 5
-
文献情報:
Rice JW et al. Small molecule inhibitors of Hsp90 potently affect inflammatory disease pathways and exhibit activity in models of rheumatoid arthritis. Arthritis Rheum. 2008 Dec;58(12):3765-75
Rice JW et al
2008/01/01
-
備考:
Application: Bioassay, Sample Type: Whole Cells -
参照:
- No.: 6
-
文献情報:
Crawford Y et al. PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment. Cancer Cell 2009 Jan;15(1):21-34
Crawford Y et al
2009/01/01
-
備考:
Application: Western Blot Control, Sample Type: N/A -
参照:
- No.: 7
-
文献情報:
Liu J et al. PDGF-D improves drug delivery and efficacy via vascular normalization, but promotes lymphatic metastasis by activating CXCR4 in breast cancer. Clin. Cancer Res. 2011 Jun;17(11):3638-48
Liu J et al
2011/01/01
-
備考:
Application: Bioassay, Sample Type: Whole Cells -
参照:
- No.: 8
-
文献情報:
Wilson TR et al. Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature 2012 Jul;487(7408):505-9
Wilson TR et al
2012/01/01
-
備考:
Application: Bioassay, Sample Type: Whole Cells -
参照:
- No.: 9
-
文献情報:
Petti LM et al. A single amino acid substitution converts a transmembrane protein activator of the platelet-derived growth factor β receptor into an inhibitor. J. Biol. Chem. 2013 Sep;288(38):27273-86
Petti LM et al
2013/01/01
-
備考:
Application: Bioassay, Sample Type: Whole Cells -
参照:
- No.: 10
-
文献情報:
Obenauf AC et al. Therapy-induced tumour secretomes promote resistance and tumour progression. Nature 2015 Apr;520(7547):368-72
Obenauf AC et al
2015/01/01
-
備考:
Application: Bioassay, Sample Type: Whole Cells -
参照:
- No.: 11
-
文献情報:
Heim EN et al. Biologically active LIL proteins built with minimal chemical diversity. Proc. Natl. Acad. Sci. U.S.A. 2015 Aug;112(34):E4717-25
Heim EN et al
2015/01/01
-
備考:
Application: Bioassay, Sample Type: Whole Cells -
参照: